Share sensitive information only on official, secure websites. Please note: This report has been corrected. An erratum has been published. Kimberly A. Workowski, MD 1 ,2 ; Laura H. Bachmann, MD 1 ; Philip A. Chan, MD 1 ,3 ; Christine M. Johnston, MD 1 ,4 ; Christina A. Zenilman, MD 1 ,8 ; Gail A. Bolan, MD 1 View author affiliations. These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections STIs were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11β14, The information in this report updates the guidelines.
These guidelines discuss 1 updated recommendations for treatment of Neisseria gonorrhoeae , Chlamydia trachomatis , and Trichomonas vaginalis ; 2 addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3 alternative treatment options for bacterial vaginosis; 4 management of Mycoplasma genitalium ; 5 human papillomavirus vaccine recommendations and counseling messages; 6 expanded risk factors for syphilis testing among pregnant women; 7 one-time testing for hepatitis C infection; 8 evaluation of men who have sex with men after sexual assault; and 9 two-step testing for serologic diagnosis of genital herpes simplex virus.
Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs. Physicians and other health care providers have a crucial role in preventing and treating STIs. These guidelines are intended to assist with that effort. Although the guidelines emphasize treatment, prevention strategies and diagnostic recommendations also are discussed.
This report updates Sexually Transmitted Diseases Treatment Guidelines, 1 and should be regarded as a source of clinical guidance rather than prescriptive standards. Health care providers should always consider the clinical circumstances of each person in the context of local disease prevalence. These guidelines are focused on treatment and counseling and do not address other community services and interventions that are essential to STI and HIV prevention efforts.
This guidance specifies operational determinants of quality services in various clinical settings, describes on-site treatment and partner services, and indicates when STI-related conditions should be managed through consultation with or referral to a specialist.
